Fig. 4From: Development and validation of prognostic markers in sarcomas base on a multi-omics analysisa Frequency distributions of Gain and Loss in CNV. b Frequency distributions of Gain and MetHyper. c Frequency distributions of Gain and MetHypo. d Frequency distributions of CNV Loss and MetHyper. e Frequency distributions of CNV Loss and MetHypo. f Frequency distributions of MetHyper and MetHypoBack to article page